0001209191-22-028726.txt : 20220512 0001209191-22-028726.hdr.sgml : 20220512 20220512212303 ACCESSION NUMBER: 0001209191-22-028726 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220510 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Longpre Lara CENTRAL INDEX KEY: 0001780347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38981 FILM NUMBER: 22919928 MAIL ADDRESS: STREET 1: C/O MIRUM PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirum Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001759425 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831281555 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-667-4085 MAIL ADDRESS: STREET 1: 950 TOWER LANE, SUITE 1050 CITY: FOSTER CITY STATE: CA ZIP: 94404 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-10 0 0001759425 Mirum Pharmaceuticals, Inc. MIRM 0001780347 Longpre Lara C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 0 1 0 0 Chief Development Officer Common Stock 2022-05-10 5 A 0 E 1454 13.566 A 96452 D This Form 4 is being filed voluntarily to report the acquisition of 1,454 shares by the Reporting Person on May 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan. /s/ Jody Howe, Attorney-in-Fact 2022-05-12